These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. DOPAN IN LYMPHOGRANULOMATOSIS. ITS IMMEDIATE AND DISTANT RESULTS. IVANOVA EM Acta Unio Int Contra Cancrum; 1964; 20():375-6. PubMed ID: 14151933 [No Abstract] [Full Text] [Related]
3. THERAPEUTIC EFFECT OF ANTICANCER DRUGS ON SKIN CANCER. HIGUCHI K; UEMATSU K Kyushu J Med Sci; 1963 Oct; 14():203-9. PubMed ID: 14104458 [No Abstract] [Full Text] [Related]
4. [EXPERIMENTAL AND CLINICAL FINDINGS ON THE THERAPEUTIC USE OF A NEW ALKYLATING DRUG: URACIL MUSTARD]. BALLERINI G; CASTOLDI G; RICCI N; TENZE L Clin Ter; 1965 Jan; 32():49-61. PubMed ID: 14262587 [No Abstract] [Full Text] [Related]
5. [REDUCING THE TOXICITY OF DOPAN BY MEANS OF AMINOETHYL-ISOTHIURONIUM (AET) IN EXPERIMENTS ON MONKEYS]. SPASSKAIA IG; PLATONOVA GN; SOLOPAEVA IM; SEMENOV LF; ZEITUNIAN KA; LARIONOV LF Vopr Onkol; 1963; 9():44-6. PubMed ID: 14148614 [No Abstract] [Full Text] [Related]
6. EFFECT OF TESTOSTERONE ENANTHATE AND ALKYLATING AGENTS ON MULTIPLE MYELOMA. BRODSKY I; DENNIS LH; DECASTRO NA; BRADY L; KAHN SB JAMA; 1965 Sep; 193():874-8. PubMed ID: 14341128 [No Abstract] [Full Text] [Related]
7. CLINICAL EVALUATION OF URACIL MUSTARD. WILLIAMS HM Cancer Chemother Rep; 1963 Oct; 32():73-6. PubMed ID: 14088838 [No Abstract] [Full Text] [Related]
8. [A CASE OF ACUTE POISONING WITH DOPAN]. BOGORODSKAIA TA; MIKHAILOVA EN; OGIBINA LN; SHCHERBA MM Ter Arkh; 1965 Jan; 37():107-9. PubMed ID: 14342983 [No Abstract] [Full Text] [Related]
9. URACIL MUSTARD: A POTENT INDUCER OF LUNG TUMORS IN MICE. ABELL CW; FALK HL; SHIMKIN MB; WEISBURGER EK; WEISBURGER JH; GUBAREFF N Science; 1965 Mar; 147(3664):1443-5. PubMed ID: 14268720 [TBL] [Abstract][Full Text] [Related]
10. NEUROBLASTOMA AND WILMS'S TUMOR IN INFANTS AND CHILDREN. RATNER IA Tex State J Med; 1964 Mar; 60():206-9. PubMed ID: 14131719 [No Abstract] [Full Text] [Related]
11. CURRENT STATUS OF 5-FLUOROURACIL THERAPY IN FAR-ADVANCED NEOPLASTIC DISEASE. SCHELL HW Geriatrics; 1964 Apr; 19():265-70. PubMed ID: 14141804 [No Abstract] [Full Text] [Related]
12. COMPARISON OF CYCLOPHOSPHAMIDE (CYTOXAN AND URACIL MUSTARD (U-8344) IN CHRONIC GRANULOCYTIC LEUKEMIA. FROMMEYER WB Cancer; 1964 Mar; 17():288-96. PubMed ID: 14132176 [No Abstract] [Full Text] [Related]
13. CLOSED PELVIC PERFUSION IN ADVANCED GYNECOLOGIC CANCER. CAVANAGH D; MARTIN DS; FERGUSON JH South Med J; 1965 May; 58():549-57. PubMed ID: 14280772 [No Abstract] [Full Text] [Related]
14. Evaluation of uracil mustard in children with Hodgkin's disease, lymphosarcoma, and soft tissue sarcoma. Berry DH; Sutow WW; Vietti TJ; Fernbach DJ; Sullivan MP; Haggard ME; Lane DM J Clin Pharmacol New Drugs; 1972 Apr; 12(4):169-73. PubMed ID: 4553449 [No Abstract] [Full Text] [Related]
15. PHASE I STUDIES OF PYRAZOLE (NSC-45410). FOLEY HT; SHNIDER BI; GOLD GL; UZER Y Cancer Chemother Rep; 1965 Feb; 44():45-8. PubMed ID: 14294812 [No Abstract] [Full Text] [Related]
16. CYCLOPHOSPHAMIDE (NSC-26271)-1 IN UNCOMMON MALIGNANT NEOPLASMS IN CHILDREN. HOLCOMB TM; HAGGARD ME; WINDMILLER J Cancer Chemother Rep; 1964 Mar; 36():73-5. PubMed ID: 14152279 [No Abstract] [Full Text] [Related]
17. RESULTS OF REGIONAL CHEMOTHERAPY OF NEOPLASMS OF THE UPPER BODY BY TEMPORARY MID-TORSO VASCULAR OCCLUSION. CLAPP P; TAYAO MS; MILLER DG; LAWRENCE W Cancer; 1964 Aug; 17():1012-25. PubMed ID: 14202589 [No Abstract] [Full Text] [Related]
18. AN EVALUATION OF AB-103 (NSC-37096) IN THE PALLIATIVE MANAGEMENT OF ADVANCED GASTROINTESTINAL CARCINOMA. MOERTEL CG; REITEMEIER RJ; HAHN RG Cancer Chemother Rep; 1963 Oct; 32():97-8. PubMed ID: 14088841 [No Abstract] [Full Text] [Related]